Kim HR - Search Results

1

A case of recurrent pulmonary inflammatory myofibroblastic tumor with aggressive metastasis after complete resection.

Moon CH, Yoon JH, Kang GW, Lee SH, Baek JS, Kim SY, Kim HR, Kim CH. Moon CH, et al. Among authors: kim ch, kim sy, kim hr. Tuberc Respir Dis (Seoul). 2013 Oct;75(4):165-9. doi: 10.4046/trd.2013.75.4.165. Epub 2013 Oct 29. Tuberc Respir Dis (Seoul). 2013. PMID: 24265646 Free PMC article.

2

Kim HR, Kang MS, Na II, Yang SH, Choi YH, Kang HJ, Kim CH, Lee JC. Kim HR, et al. Among authors: kim ch. J Cancer Res Clin Oncol. 2010 Apr;136(4):547-52. doi: 10.1007/s00432-009-0687-0. Epub 2009 Sep 30. J Cancer Res Clin Oncol. 2010. PMID: 19789893

3

Gallbladder cancer presenting as an isolated large lung mass.

Kim HR, Cheon GJ, Koh JS, Yang SH, Kim CH, Lee JC. Kim HR, et al. Among authors: kim ch. Clin Nucl Med. 2009 Nov;34(11):827-8. doi: 10.1097/RLU.0b013e3181b81d95. Clin Nucl Med. 2009. PMID: 19851190 No abstract available.

4

Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors.

Choi YJ, Rho JK, Jeon BS, Choi SJ, Park SC, Lee SS, Kim HR, Kim CH, Lee JC. Choi YJ, et al. Among authors: kim ch, kim hr. Cancer Chemother Pharmacol. 2010 Jul;66(2):381-8. doi: 10.1007/s00280-009-1174-7. Epub 2009 Nov 18. Cancer Chemother Pharmacol. 2010. PMID: 19921194

5

Prognostic value of E-cadherin expression in non-small cell lung cancer treated with gefitinib.

Kook EH, Kim YM, Kim HT, Koh JS, Choi YJ, Rho JK, Kim HR, Kim CH, Lee JC. Kook EH, et al. Among authors: kim ym, kim ch, kim hr, kim ht. Oncol Res. 2010;18(9):445-51. doi: 10.3727/096504010x12671222663674. Oncol Res. 2010. PMID: 20524402

6

Association between age at diagnosis and the presence of EGFR mutations in female patients with resected non-small cell lung cancer.

Choi YH, Lee JK, Kang HJ, Lee TS, Kim HR, Kim CH, Koh JS, Baek HJ, Lee JC, Na II. Choi YH, et al. Among authors: kim ch, kim hr. J Thorac Oncol. 2010 Dec;5(12):1949-52. doi: 10.1097/jto.0b013e3181f38816. J Thorac Oncol. 2010. PMID: 21155184 Free article.

7

Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.

Rho JK, Choi YJ, Jeon BS, Choi SJ, Cheon GJ, Woo SK, Kim HR, Kim CH, Choi CM, Lee JC. Rho JK, et al. Among authors: kim ch, kim hr. Mol Cancer Ther. 2010 Dec;9(12):3233-43. doi: 10.1158/1535-7163.MCT-10-0625. Mol Cancer Ther. 2010. PMID: 21159609

8

Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs.

Chung JH, Rho JK, Xu X, Lee JS, Yoon HI, Lee CT, Choi YJ, Kim HR, Kim CH, Lee JC. Chung JH, et al. Among authors: kim ch, kim hr. Lung Cancer. 2011 Aug;73(2):176-82. doi: 10.1016/j.lungcan.2010.11.011. Epub 2010 Dec 17. Lung Cancer. 2011. PMID: 21168239

9

Squamous cell carcinoma arising from pulmonary hamartoma.

Lee BJ, Kim HR, Cheon GJ, Koh JS, Kim CH, Lee JC. Lee BJ, et al. Among authors: kim ch, kim hr. Clin Nucl Med. 2011 Feb;36(2):130-1. doi: 10.1097/RLU.0b013e318203bc27. Clin Nucl Med. 2011. PMID: 21220977

10

Epidermal growth factor receptor mutations in female patients with postoperative recurrent non-small-cell lung cancer.

Na II, Kim HR, Lee JK, Park SH, Kim CH, Koh JS, Baek HJ, Choe du H. Na II, et al. Among authors: kim ch, kim hr. J Cancer Res Ther. 2012 Jul-Sep;8(3):373-8. doi: 10.4103/0973-1482.103515. J Cancer Res Ther. 2012. PMID: 23174717 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,376 results

Search Page

Filters